Kennedy Capital Management’s CorMedix CRMD Stock Holding History

Kennedy Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Sell	419,284 -254,018	-38%	-$2.01M	0.06%	386
2026 Q1	$4.57M	Buy	673,302 +15,197	+2%	+$112K	0.1%	311
2025 Q4	$7.65M	Sell	658,105 -528	-0.1%	-$5.84K	0.16%	203
2025 Q3	$7.66M	Buy	658,633 +178,455	+37%	+$2.16M	0.17%	220
2025 Q2	$5.92M	Buy	480,178 +75,947	+19%	+$838K	0.14%	250
2025 Q1	$2.49M	Buy	404,231 +25,988	+7%	+$269K	0.06%	404
2024 Q4	$3.06M	Sell	378,243 -1,701	-0.4%	-$17K	0.07%	425
2024 Q3	$3.07M	Buy	+379,944	New	+$2.06M	0.07%	413

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Kennedy Capital Management's CRMD Position: Q2 2026 in Review

Kennedy Capital Management reduced its CorMedix (CRMD) stake by 38% in Q2 2026, selling an estimated $2.01M and leaving 419,284 shares worth $3.29M. The position accounts for 0.06% of the portfolio, ranked #386.

Kennedy Capital Management first reported a position in CRMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.66M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Kennedy Capital Management held 419,284 shares of CorMedix worth $3.29M as of Q2 2026.
Kennedy Capital Management sold 254,018 CorMedix shares in Q2 2026, an estimated $2.01M.
CorMedix made up 0.06% of Kennedy Capital Management's portfolio in Q2 2026, its #386 holding.
Kennedy Capital Management first reported a position in CorMedix in Q3 2024 and has held it in 8 quarters since.
Kennedy Capital Management's CorMedix position peaked at $7.66M in Q3 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.